These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11746713)

  • 41. Evaluation of 5-(11)C-methyl-A-85380 as an imaging agent for PET investigations of brain nicotinic acetylcholine receptors.
    Iida Y; Ogawa M; Ueda M; Tominaga A; Kawashima H; Magata Y; Nishiyama S; Tsukada H; Mukai T; Saji H
    J Nucl Med; 2004 May; 45(5):878-84. PubMed ID: 15136639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adenosine (A)(2A)receptor modulation of nicotine-induced locomotor sensitization. A pharmacological and transgenic approach.
    Jastrzębska J; Nowak E; Smaga I; Bystrowska B; Frankowska M; Bader M; Filip M; Fuxe K
    Neuropharmacology; 2014 Jun; 81():318-26. PubMed ID: 24632528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tricyclic oxazolo[2,3-f]purinediones: potency as adenosine receptor ligands and anticonvulsants.
    Drabczyńska A; Müller CE; Schumacher B; Hinz S; Karolak-Wojciechowska J; Michalak B; Pekala E; Kieć-Kononowicz K
    Bioorg Med Chem; 2004 Sep; 12(18):4895-908. PubMed ID: 15336269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists.
    Baraldi PG; Cacciari B; Spalluto G; Pineda de las Infantas y Villatoro MJ; Zocchi C; Dionisotti S; Ongini E
    J Med Chem; 1996 Mar; 39(5):1164-71. PubMed ID: 8676354
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
    Chattopadhyay S; Xue B; Collins D; Pichika R; Bagnera R; Leslie FM; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    J Nucl Med; 2005 Jan; 46(1):130-40. PubMed ID: 15632043
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.
    Zocchi C; Ongini E; Conti A; Monopoli A; Negretti A; Baraldi PG; Dionisotti S
    J Pharmacol Exp Ther; 1996 Feb; 276(2):398-404. PubMed ID: 8632302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preclinical studies on [11C]TMSX for mapping adenosine A2A receptors by positron emission tomography.
    Ishiwata K; Wang WF; Kimura Y; Kawamura K; Ishii K
    Ann Nucl Med; 2003 May; 17(3):205-11. PubMed ID: 12846542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [2-11C]isopropyl-, [1-11C]ethyl-, and [11C]methyl-labeled phenoxyphenyl acetamide derivatives as positron emission tomography ligands for the peripheral benzodiazepine receptor: radiosynthesis, uptake, and in vivo binding in brain.
    Zhang MR; Ogawa M; Maeda J; Ito T; Noguchi J; Kumata K; Okauchi T; Suhara T; Suzuki K
    J Med Chem; 2006 May; 49(9):2735-42. PubMed ID: 16640334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM).
    Huang Y; Hwang DR; Bae SA; Sudo Y; Guo N; Zhu Z; Narendran R; Laruelle M
    Nucl Med Biol; 2004 Jul; 31(5):543-56. PubMed ID: 15219271
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Derivatives of 4,6-diamino-1,2-dihydro-2-phenyl-1,2,4-triazolo[4,3-a]quinoxalin-2H-1-one: potential antagonist ligands for imaging the A2A adenosine receptor by positron emission tomography (PET).
    Holschbach MH; Bier D; Wutz W; Sihver W; Schüller M; Olsson RA
    Eur J Med Chem; 2005 May; 40(5):421-37. PubMed ID: 15893016
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of radioiodinated 8-Cyclopentyl-3-[(E)-3-iodoprop-2-en-1-yl]-1-propylxanthine ([*I]CPIPX) as a new potential A1 adenosine receptor antagonist for SPECT.
    Sihver W; Holschbach MH; Bier D; Wutz W; Schulze A; Olsson RA; Coenen HH
    Nucl Med Biol; 2003 Aug; 30(6):661-8. PubMed ID: 12900292
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Vuorimaa A; Rissanen E; Airas L
    Contrast Media Mol Imaging; 2017; 2017():6975841. PubMed ID: 29348737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand.
    Zhang L; Villalobos A; Beck EM; Bocan T; Chappie TA; Chen L; Grimwood S; Heck SD; Helal CJ; Hou X; Humphrey JM; Lu J; Skaddan MB; McCarthy TJ; Verhoest PR; Wager TT; Zasadny K
    J Med Chem; 2013 Jun; 56(11):4568-79. PubMed ID: 23651455
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo imaging of adenosine A1 receptors in the human brain with [18F]CPFPX and positron emission tomography.
    Bauer A; Holschbach MH; Meyer PT; Boy C; Herzog H; Olsson RA; Coenen HH; Zilles K
    Neuroimage; 2003 Aug; 19(4):1760-9. PubMed ID: 12948730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiosynthesis and In Vitro Evaluation of [
    Humpert S; Schneider D; Lang M; Schulze A; Neumaier F; Holschbach M; Bier D; Neumaier B
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of the lipid emulsion on an injectable formulation of lipophilic KW-3902, a newly synthesized adenosine A1-receptor antagonist.
    Hosokawa T; Yamauchi M; Yamamoto Y; Iwata K; Mochizuki H; Kato Y
    Biol Pharm Bull; 2002 Apr; 25(4):492-8. PubMed ID: 11995931
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of the adenosine A(2A) antagonist KW-6002 on motor and motivational processes in the rat.
    O'Neill M; Brown VJ
    Psychopharmacology (Berl); 2006 Jan; 184(1):46-55. PubMed ID: 16344986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [1-11C]octanoate as a potential PET tracer for studying glial functions: PET evaluation in rats and cats.
    Kuge Y; Kawashima H; Yamazaki S; Hashimoto N; Miyake Y
    Nucl Med Biol; 1996 Nov; 23(8):1009-12. PubMed ID: 9004290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of PET radiopharmaceuticals and their clinical applications at the Positron Medical Center.
    Ishiwata K; Kimura Y; Oda K; Ishii K; Sakata M; Kawasaki K; Nariai T; Suzuki Y; Ishibashi K; Mishina M; Hashimoto M; Ishikawa M; Toyohara J
    Geriatr Gerontol Int; 2010 Jul; 10 Suppl 1():S180-96. PubMed ID: 20590833
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.